Leukotriene B4 plays a pivotal role in CD40 dependent activation of chronic B lymphocytic leukemia cells.

被引:0
|
作者
Claesson, HE
Runarsson, G
Liu, AQ
Mahshid, Y
Feltenmark, S
Klein, E
Bjorkholm, M
机构
[1] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4808
引用
收藏
页码:285B / 285B
页数:1
相关论文
共 50 条
  • [21] The role of the CD40 antigen on malignant B cells
    Planken, EV
    Willemze, R
    KluinNelemans, JC
    LEUKEMIA & LYMPHOMA, 1996, 22 (3-4) : 229 - 235
  • [22] Resistance to Fas-induced apoptosis in CD40-activated B-CHRONIC lymphocytic leukemia cells.
    NeidhardtBerard, EM
    Garcia, E
    Durand, I
    Coiffier, B
    Salles, G
    Banchereau, J
    Garrone, P
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 73 - 73
  • [23] Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors
    Weller, CL
    Collington, SJ
    Brown, JK
    Miller, HRP
    Al-Kashi, A
    Clark, P
    Jose, PJ
    Hartnell, A
    Williams, TJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (12): : 1961 - 1971
  • [24] RESPONSIVENESS OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS ACTIVATED VIA SURFACE IGS OR CD40 TO B-CELL TROPIC FACTORS
    FLUCKIGER, AC
    ROSSI, JF
    BUSSEL, A
    BRYON, P
    BANCHEREAU, J
    DEFRANCE, T
    BLOOD, 1992, 80 (12) : 3173 - 3181
  • [25] All B cells are not the same: a story of CD40 activation
    Byrd, JC
    BLOOD, 2004, 104 (13) : 3847 - 3847
  • [26] Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
    Granziero, L
    Ghia, P
    Circosta, P
    Gottardi, D
    Strola, G
    Geuna, M
    Montagna, L
    Piccoli, P
    Chilosi, M
    Caligaris-Cappio, F
    BLOOD, 2001, 97 (09) : 2777 - 2783
  • [27] B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL
    Ferrer, Gerardo
    Bosch, Rosa
    Hodgson, Kate
    Tejero, Rut
    Roue, Gael
    Colomer, Dolors
    Montserrat, Emili
    Moreno, Carol
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (04) : 570 - 578
  • [28] Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-Cell type costimulatory capacity
    Schattner, EJ
    Mascarenhas, J
    Reyfman, I
    Koshy, M
    Woo, C
    Friedman, SM
    Crow, MK
    BLOOD, 1998, 91 (08) : 2689 - 2697
  • [29] Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes
    Takahashi, S
    Rousseau, RF
    Yotnda, P
    Mei, ZY
    Dotti, G
    Rill, D
    Hurwitz, R
    Marini, F
    Andreeff, M
    Brenner, MK
    HUMAN GENE THERAPY, 2001, 12 (06) : 659 - 670
  • [30] Aberrant expression of trail in B chronic lymphocytic leukemia (B-CLL) cells.
    Tiribelli, M
    Barbarotto, E
    Celeghini, C
    Michelutti, A
    Zauli, G
    Fanin, R
    Secchiero, P
    BLOOD, 2005, 106 (11) : 325B - 325B